SHEA Guidelines and Position Papers
These papers are provided as a professional courtesy by SHEA and the University of Chicago Press to be used for educational purposes only. They may not be reproduced or used for commercial purposes without written permission from SHEA.
Antimicrobial Stewardship
Guidelines for developing an institutional program to enhance antimicrobial stewardship
Joint SHEA/IDSA Taskforce
CID January 2007
Guidelines for the prevention of antimicrobial resistance in hospitals
SHEA/IDSA Joint Committee on the Prevention of Antimicrobial Resistance
ICHE April 1997
Clostridium difficile
Clinical Practice Guidelines for Clostridium difficile Infection in Adults
SHEA/IDSA
ICHE May 2010
Recommendations for surveillance of Clostridium difficile-associated disease
Ad Hoc Clostridium difficile Surveillance Working Group
ICHE February 2007
Clostridium difficile in long-term-care facilities for the elderly
SHEA Long-Term–Care Committee
ICHE December 2002
Clostridium difficile-associated diarrhea and colitis
ICHE August 1995
Compendium of Strategies to Prevent HAIs in Acute Care Hospitals
- Full Document
- Editorial
- Introduction
- Surgical Site Infection (SSI)
- Central Line-Associated Bloodstream Infection (CLABSI)
- Catheter-Associated Urinary Tract Infection (CAUTI)
- Ventilator-Associated Pneumonia (VAP)
- Clostridium difficile
- Methicillin-Resistant Staphylococcus aureus (MRSA)
Hand Hygiene
Guideline for hand hygiene in healthcare settings
SHEA/HICPAC/APIC/IDSA Hand Hygiene Taskforce
ICHE December 2002
Healthcare Epidemiology
Recommendations for metrics for multidrug-resistant organisms in healthcare settings: SHEA/HICPAC position paper
HICPAC/SHEA
ICHE October 2008
How to select and interpret molecular strain typing methods for epidemiological studies of bacterial infections: A review for healthcare epidemiologists
Molecular Typing Working Group of SHEA
ICHE June 1997
An approach to the evaluation of quality indicators of the outcome of care in hospitalized patients
Quality Indicator Study Group
ICHE May 1995
Infection Prevention and Control
Guideline for Disinfection and Sterilization of Prion-Contaminated Medical Instruments
SHEA
February 2010
Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplantation Recipients: A Global Perspective
Biol Blood Marrow Transplant. 2009 Oct;15(10):1143-238.
SHEA; IDSA; Center for International Blood and Marrow Research; National Marrow Donor Program; European Blood and MarrowTransplant Group; American Society of Blood and Marrow Transplantation; Canadian Blood and Marrow Transplant Group; AMMI-Canada; CDC; University of Minnesota, Minneapolis, MN, USA.
PMID: 19747629
Recommendations for metrics for multidrug-resistant organisms in healthcare settings: SHEA/HICPAC position paper
HICPAC/SHEA
ICHE October 2008
Raising standards while watching the bottom line: Making a business case for infection control
ICHE October 2007
Infection control recommendations for patients with cystic fibrosis: microbiology, important pathogens, and infection control practices to prevent patient-to-patient transmission
Cystic Fibrosis Foundation Consensus Conference on Infection Control Participants
ICHE May 2003
Multi-society guideline for reprocessing flexible gastrointestinal endoscopes
SHEA/ASGE/JCAHO/ASCRS/APIC/FASA
ICHE July 2003
Guidelines for the prevention of intravascular catheter-related infections
SHEA/HICPAC
ICHE December 2002
Requirements for infrastructure and essential activities of infection control and epidemiology in hospitals
SHEA/APIC/JCAHO/AHA/CDC/PIDS/IDSA/NFID
ICHE February 1998
Medical waste
ICHE January 1992
Influenza
Position Paper: Antiviral stockpiling for influenza preparedness
SHEA/IDSA
October 2005
Position paper: Influenza vaccination of healthcare workers
ICHE November 2005
Legislative Mandates
Essentials of public reporting of healthcare-associated infections: A tool kit
Healthcare-Associated Infection Working Group of the Joint Public Policy Committee (SHEA/APIC/CSTE/CDC)
ICHE January 2007
Legislative mandates for use of active surveillance cultures to screen for MRSA and VRE
Joint SHEA/APIC Taskforce
ICHE January 2007
APIC/IDSA/SHEA model legislation for public reporting of healthcare-associated infections
January 2006
Position Paper: Public disclosure of healthcare-associated infections: the role of SHEA
ICHE February 2005
Long-Term Care
Infection prevention and control in the long-term care facility
SHEA/APIC
ICHE July 2008
Clostridium difficile in long-term-care facilities for the elderly
SHEA Long-Term Care Committee
ICHE December 2002
Urinary tract infections in long-term-care facilities
SHEA Long-Term-Care Committee
March 2001
Infection prevention and control in the long-term-care facility
SHEA/APIC
ICHE December 1997
Antimicrobial resistance in long-term-care facilities
ICHE February 1996
Antimicrobial use in long-term-care facilities
SHEA Long-Term Care Committee
ICHE February 1996
MRSA and VRE
Legislative mandates for use of active surveillance cultures to screen for MRSA and VRE
Joint SHEA/APIC Taskforce
ICHE January 2007
= Members Only Content